Skip to search boxSkip to navigationSkip to main content

Three Technologies That Will Guide Revascularization of Chronic Coronary Syndrome Patients into the 21st Century: A Review

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Open access

Abstract

Although medical therapy is the preferred first-line treatment for patients with chronic coronary syndrome (CCS), revascularization remains an important consideration. We present a review that identifies the three diagnostic technologies most important to guiding the decision to revascularize patients with CCS: (1) cardiac computed tomography, (2) intracoronary imaging, and (3) lesion-specific physiological guidance.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 212-220 (9 pages)

Journal (Volume, Issue Number)

International Journal of Angiology (Volume 30, Issue 3)

Publication milestones

  • Published - 11/10/2021

Publication status

Published - 11/10/2021

ISSN

1061-1711

Publication IDs

  • Scopus: 85114103359

Publication metrics

Metrics

Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
1

Funding Details

Dr. Winkler receives research support from Terarecon, Ziosoft, Algomedica, and Teleflex. Dr. Arora receives research support from Terarecon. Dr. Weintraub is funded by grants from the National Institutes of Health (HL142097, HL134354, R56AG064895, and AR070029).
FunderFunding numbers
NIH
HL134354, R56AG064895, HL142097, AR070029